The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction

Overcoming dendritic cell (DC) dysfunction is a prerequisite for successful active immunotherapy against breast cancer. CD40 ligand (CD40L), a key molecule in the interface between T-lymphocytes and DCs, seems to be instrumental in achieving that goal. Commenting on our data that CD40L protects circ...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinzon-Charry, Alberto, Schmidt, Chris W, López, José Alejandro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413976/
https://www.ncbi.nlm.nih.gov/pubmed/16524455
http://dx.doi.org/10.1186/bcr1386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413976/
https://www.ncbi.nlm.nih.gov/pubmed/16524455
http://dx.doi.org/10.1186/bcr1386

Ejemplares similares